You are here

Eli Lilly

Lilly’s Retevmo receives FDA approval to treat solid tumours

Pharmaceutical Business Review

Thu, 09/22/22 - 10:13 am

metastatic solid tumors

Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts

Fierce Pharma

Thu, 09/15/22 - 10:34 am

AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say

Morningstar

Wed, 09/14/22 - 09:31 am

SpringWorks, Eli Lilly and More Release Data Ahead of ESMO

BioSpace

Thu, 09/8/22 - 04:30 pm

SpringWorks Therapeutics

Brace for an end-of-year boost to drug approvals

EP Vantage

Fri, 09/2/22 - 12:14 pm

Alnylam Pharmaceuticals

Apellis Pharmaceuticals

Bristol Myers Squibb

Gilead Sciences

Mirati Therapeutics

Moderna Therapeutics

TG Therapeutics

Travere Therapeutics

Drug makers leave the pain behind

EP Vantage

Fri, 08/26/22 - 10:26 am

Ampio Pharmaceuticals

Eliem Therapeutics

Teva Pharamceutical

Vertex Pharmaceuticals

How Eli Lilly Is Thinning Out the Competition

Motley Fool

Wed, 08/17/22 - 11:46 am

Eli Lilly says Indiana's abortion ban will force it to hire more outside the state

Fierce Pharma

Mon, 08/8/22 - 10:08 am

Lilly takes long view on Alzheimer’s drug hopeful as FDA starts expedited review

BioPharma Dive

Fri, 08/5/22 - 10:59 am

Alzheimer's disease

Eli Lilly CEO Ricks echoes a growing refrain on price negotiations: 'We’ll focus our resources on other areas'

Endpoints

Fri, 08/5/22 - 10:47 am

Eli Lilly ordered to pay $61M over false rebate calculations

Beckers Hospital Review

Thu, 08/4/22 - 06:25 pm

Despite drug launch streak, Lilly posts rare sales decline as Alimta succumbs to generics

Fierce Pharma

Thu, 08/4/22 - 12:01 pm

Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts

Fierce Pharma

Mon, 08/1/22 - 10:53 am

A year after netting Takeda partnership, small molecule startup arms itself with some new cash

Endpoints

Wed, 07/27/22 - 10:52 am

BridGene Biosciences

Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?

Fierce Biotech

Fri, 07/22/22 - 11:21 am

Alzheimer's disease

Innovent & Eli Lilly's Type 2 Diabetes Drug Lowers HbA1c, Scores Early Win

BioSpace

Tue, 07/19/22 - 10:26 am

type 2 diabetes

clinical trials

Lilly taps Triastek to use 3D printing for gut-targeted drug delivery

Fierce Pharma

Mon, 07/18/22 - 09:55 am

Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts

Fierce Pharma

Sun, 07/17/22 - 11:07 pm

FDA Has Ways to Go to Keep Pace with 2020/21 Approvals

BioSpace

Wed, 07/6/22 - 11:05 am

Bristol Myers Squibb

Chasing AnaptysBio and Lilly, MiroBio rounds up $97M for autoimmune checkpoint agonist clinical trials

Fierce Biotech

Wed, 06/29/22 - 10:51 am

venture capital

autoimmune disease

Pages